期刊文献+

血栓通致不良反应病例分析及发生机制探讨 被引量:5

Cases Analysis and Mechanism of 19 Cases of Adverse Drug Reactions Induced by Xueshuantong Injection
下载PDF
导出
摘要 目的了解郑州某综合医院血栓通致不良反应(ADR)的一般规律、临床特点及发生原因,为临床合理用药提供参考。方法对医院2013年1月至12月各病区上报的血栓通致ADR 19例患者的资料进行分析,以患者一般情况、给药过程及ADR临床表现等作为考察项,并对其发生机制进行探讨。对患者年龄、性别、ADR发生时间及累及系统分布进行统计学分析。结果血栓通ADR发生率为0.57%,多发生于50岁以上年龄段患者(57.89%,P<0.05);用药首次或再次用药时均可能发生,多发生在用药30 min以内(89.47%);以皮肤及其附件损害(54.54%)为主,且均为新的ADR。结论血栓通致ADR时有发生且作用机制复杂,临床应用时应密切关注患者的病情变化,保证用药安全。 Objective To analyze the clinical characteristics and causes of adverse drug reactions( ADR) induced by Xueshuantong Injection,and to provide references for the rational drug use.Methods The ordinary circumstances,dosage of sodium,clinical manifestation and the mechanism were analyzed statistically of 19 ADRs induced by Xueshuantong Injection from January to December 2013 of a hospital,and its mechanism was investigated.The age,sex,time distribution and systems involved of the ADRs patients were performed statistical analysis.Results The ADRs rate of Xueshuantong Injection was 0.57%,and 57.89% of the patients were over the age of 50 years old( P 〈 0.05).Most patients( 89.47%) suffered from ADRs in 30 min after administration,and 54.54% were skin reactions( P 〈 0.05).All of the cases were new ADRs.Conclusion The adverse reactions induced by Xueshuantong Injection occurred occasionally with complex mechanism,and the patient’s condition changes should pay close attention to in the clinical application,to ensure the safety of medication.
作者 彭昊帅 李广辉 张文兴 Peng Haoshuai Li Guanghui Zhang Wenxing(Department of Pharmacy, Zhengzhou Central Hospital, Zheagzhou, Henaa, China 450053 Function Test Center, Inner Mongolia Medical University, Huhhot, Inner Mongolia, China 010059)
出处 《中国药业》 CAS 2017年第7期78-82,共5页 China Pharmaceuticals
关键词 血栓通 不良反应 案例分析 发生机制 Xueshuantong Injection adverse drug reaction case analysis mechanism
  • 相关文献

参考文献13

二级参考文献62

共引文献178

同被引文献69

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部